Clinical Trial Update: One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids [Phase 2]

View source ↗

Summary

Phase 2 dose-response study of AZD1981 in asthma patients uncontrolled on inhaled steroids has completed. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD1981

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-13